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Abstract
Background: It is estimated that over 60% of adults with asthma have uncontrolled symptoms, representing a substantial health
and economic impact. The effects of the home environment and exposure to volatile organic compounds (VOCs) and fine
particulate matter (PM2.5) on adults with asthma remain unknown. In addition, methods currently used to assess the home
environment do not capture real-time data on potentially modifiable environmental exposures or their effect on asthma symptoms.
Objective: The aims of this study are to (1) determine the feasibility and usability of ecological momentary assessment (EMA)
to assess self-report residential environmental exposures and asthma symptoms, home monitoring of objective environmental
exposures (total VOCs and PM2.5), and lung function in terms of forced expiratory volume in 1 second (FEV1%); (2) assess the
frequency and level of residential environmental exposures (eg, disinfectants/cleaners, secondhand smoke) via self-reported data
and home monitoring objective measures; (3) assess the level of asthma control as indicated by self-reported asthma symptoms
and lung function; and (4) explore associations of self-reported and objective measures of residential environmental exposures
with self-reported and objective measures of asthma control.
Methods: We will recruit 50 adults with asthma who have completed our online Global COVID-19 Asthma Study, indicated
willingness to be contacted for future studies, reported high use of disinfectant/cleaning products, and have asthma that is not
well controlled. Participants will receive an indoor air quality monitor and a home spirometer to measure VOCs, PM2.5, and
FEV1%, respectively. EMA data will be collected using a personal smartphone and EMA software platform. Participants will be
sent scheduled and random EMA notifications to assess asthma symptoms, environmental exposures, lung function, and mitigation
strategies. After the 14-day data collection period, participants will respond to survey items related to acceptability, appropriateness,
and feasibility.
Results: This study was funded in March 2021. We pilot tested our procedures and began recruitment in April 2022. The
anticipated completion of the study is 2023.
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Conclusions: Findings from this feasibility study will support a powered study to address the impact of home environmental
exposures on asthma symptoms and develop tailored, home-based asthma interventions that are responsive to the changing home
environment and home routines.
Trial Registration: ClinicalTrials.gov NCT05224076; https://clinicaltrials.gov/ct2/show/NCT05224076
International Registered Report Identifier (IRRID): DERR1-10.2196/39887
(JMIR Res Protoc 2022;11(8):e39887) doi: 10.2196/39887
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Introduction
Background
Asthma is a disease of chronic airway inflammation that affects
1 in 12 adults in the United States [1]. Despite effective
treatments for asthma, it is estimated that over 60% of adults
with asthma have uncontrolled symptoms [2]. Poorly controlled
asthma increases the risk of severe asthma exacerbations, which
may result in missed workdays, emergency room visits, and
hospitalizations [3].
Adults usually spend the majority of their day indoors (~15
hours/day) [4,5], and during the COVID-19 pandemic, the
number of hours spent at home increased due to lockdown orders
and personal precautions. Environmental triggers of asthma
identified in residential settings include aeroallergens (eg, dust
mites, animal dander), moisture, tobacco smoke, particulate
matter (PM), volatile organic compounds (VOCs), and nitrogen
dioxide [3,6,7]. In adults with asthma, indoor residential air
quality has been associated with decreased general health,
airway inflammation, asthma exacerbation, and decreased lung
function [8-12]. In particular, there is strong evidence suggesting
that indoor VOCs, especially aromatic and aliphatic compounds,
are associated with increased asthma symptoms [12].
VOCs are widely used as ingredients in household products,
including cleaning, disinfecting, cosmetic, degreasing, and
hobby products. Early in the pandemic, it was recommended
to disinfect surfaces with a US Environmental Protection
Agency (EPA)–registered household disinfectant [13]. While
the effects of disinfectants on adults with asthma have been
widely explored in occupational settings, less is known about
their impact in the home environment. Our team examined
disinfectant use by adults with asthma using an online global
survey between May and October 2020. We found a dramatic
increase in household disinfectant use during the pandemic, and
this correlated with poorer asthma control [14]. What is not
known is the extent to which adults with asthma routinely
engage in these types of practices, how often they
clean/disinfect, and what impact these practices have on their
asthma. In addition, data on how these environmental exposures
impact asthma symptoms in real time are not available.
PM are small particles or liquid droplets that include acids,
organic chemicals, metals, soils, dust, and allergens [15].
Common indoor sources of particulates include vacuum cleaner
bags, printers, cooking, secondhand smoke, wood combustion
in fireplaces or stoves, dust, pet hair, mold, candles, and outside
and biological sources [10,16]. A study found that
https://www.researchprotocols.org/2022/8/e39887
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concentrations of fine particulates less than 2.5 micrometers
(PM2.5) were highest indoors in homes (versus outdoors or in
offices) on weekends when participants wearing personal air
quality monitors were at home for longer periods [17], thus
supporting the increased potential exposure to particulates during
the COVID-19 pandemic. PM2.5 have been shown to affect
cardiovascular health, anxiety, cognitive function, and
respiratory health [16]. However, the effects of indoor PM2.5
on asthma are still unclear [12]. Increased frequency and severity
of asthma exacerbations, symptoms, hospitalizations, and
mortality were associated with increased ambient PM2.5 [18-21].
Existing research on VOCs and particulate matter provides a
strong scientific premise for further exploration of these
exposures in the home. We aim to extend the existing research
to develop innovative intervention strategies for those with
asthma, thereby addressing the impact of changes in
environmental exposures related but not limited to COVID-19
and enhancing our preparedness for future infectious disease
outbreaks.
Collecting home air quality data and asthma symptoms typically
rely on subjective patient report, which is impacted by recall
bias and resource-intensive methods, such as collection of
environmental samples from homes. These methods have made
it difficult to fully assess the impact of potentially modifiable
home environmental exposures on asthma symptoms in real
time or provide practical and timely interventions to reduce
exposures and disease burden. Ecological momentary assessment
(EMA) allows for the collection of time-dependent, real-time
data on self-report measures. Thus, EMA reduces potential
biases and enhances ecological validity by taking measurements
in real time in the settings where they occur, providing
high-quality longitudinal data. EMA has been increasingly
applied to diseases impacted by lifestyle and outdoor
environmental exposures, including studies of asthma-related
exposures [3-5]. Yet, there is limited research utilizing EMA
to capture in real-time the impact of home environmental
exposures on asthma symptoms. To complement EMA-captured
subjective data on symptoms, recently developed commercial
home environment sensors, such as the Awair system, have
been increasingly used to efficiently collect objective and
continuous data on multiple measures of home air quality (eg,
VOCs, PM2.5). These validated sensors and EMA provide
real-time environmental exposure data; however, they have yet
to be used to examine the home air quality of adults with asthma
and its associations with symptoms in real time [22-25].
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Accordingly, this study aims to assess the feasibility and
usability of EMA to capture the context of real-time behaviors
and environmental exposures that impact indoor environments.
In addition, this study assesses the feasibility and usability of
providing participants with an indoor air quality monitor (Awair
Omni) to continuously capture total VOCs and PM2.5. This
design will allow us to alert participants of high levels of VOCs
and PM2.5 and collect real-time data on exposure and asthma
symptoms. Daily and exposure-related lung function will be
measured with a low-cost home spirometer. Finally, we will
examine the effect of residential environmental exposures that
may be related to time spent at home and the associations
between these exposures and asthma control. In this paper, we
will describe the study protocol and outline how multiple

Nyenhuis et al
commercially available technologies that measure air quality,
lung function, and EMA were harmoniously blended and refined
prior to pilot testing.

Conceptual Framework
Research efforts that focus on indoor home environments are
essential to elucidate the possible extent of exposures that can
impact asthma outcomes and further exacerbate the risk of
hospitalization in a time when home and health care resources
continue to be strained. We illustrate the goals of our feasibility
study and the impacts we intend to accomplish using the
Translational Research Framework [26,27]. This feasibility
study will assess residential exposures of disinfectants and
particulates with the goal of reducing exposures and improving
asthma outcomes (Figure 1).

Figure 1. Application of the National Institute of Environmental Health Sciences (NIEHS) Translational Research Framework. EMA: ecological
momentary assessment.

Objectives
The aims of this study are to (1) determine the feasibility and
usability of EMA to assess self-report residential environmental
exposures and asthma symptoms, home monitoring of objective
environmental exposures (total VOCs and PM2.5), and lung
function in terms of forced expiratory volume in 1 second
(FEV1%); (2) assess the frequency and level of residential
environmental exposures (eg, disinfectants/cleaners, secondhand
smoke) via self-reported data and home monitoring objective
measures; (3) assess the level of asthma control as indicated by
self-reported asthma symptoms and lung function; and (4)
explore associations of self-reported and objective measures of
residential environmental exposures with self-reported and
objective measures of asthma control.
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Methods
Project Overview
We will recruit 50 adults with asthma who completed our online
Global COVID-19 Asthma Study (GCAS), indicated willingness
to be contacted for future research, reported high use of
disinfectant/cleaning products, and have suboptimally controlled
asthma [14]. Participants will receive an indoor air quality
monitor and a home spirometer to measure VOCs, PM2.5, and
forced expiratory volume in 1 second (FEV1%), respectively.
EMA survey data will be collected using a personal smartphone
and the PiLR Health software platform [28]. Participants will
be sent scheduled and random EMA notifications to assess
asthma symptoms, environmental exposures, lung function, and
mitigation strategies. After the 14-day data collection period,
participants will respond to survey items related to acceptability,
JMIR Res Protoc 2022 | vol. 11 | iss. 8 | e39887 | p. 3
(page number not for citation purposes)

JMIR RESEARCH PROTOCOLS

Nyenhuis et al

appropriateness, and feasibility. In addition, a random sample
of 20 participants will be interviewed to provide further insights.

Ethics Approval
All studies were conducted in accordance with the Declaration
of Helsinki and the International Conference on Harmonization
Good Clinical Practice guidelines and approved by the relevant
institutional review boards at the University of Kansas
(STUDY00145830), University of Louisville (21.0466),
University of Illinois Chicago (2020-0851), and University of
Chicago (22-0767).

Study Components
Figure 2 shows the study components. The Awair Omni Indoor
Air Quality Monitor continuously monitors about 1000 square

feet of indoor air for 7 air quality indicators: total VOC, PM2.5,
temperature, humidity, carbon dioxide, ambient light, and
ambient noise [29]. This feasibility study will only focus on
VOCs and PM2.5 levels (Table 1). The Awair Omni device
measures about 4 × 4 × 1.3 inches, is Wi-Fi and
Bluetooth–enabled, plugs into a standard alternating current
(AC) outlet, and includes an 8-hour battery backup. An air
quality reading will be taken every 10 seconds and real-time
data uploaded to a dashboard accessed only by research
personnel. The Awair Omni proprietary dashboard provides
secure communication between the Awair Omni and its
dashboard. Data will be exported from the dashboard as a .CSV
file [30-34].

Figure 2. Study components. EMA: ecological momentary assessment; PM2.5: fine particulate matter; VOC: volatile organic compound.

Table 1. Type and range of air quality measures.

a

Exposure

Sensor

Detectable range/ accuracy

Optimal range

VOCsa

Multipixel metal oxide semiconductor gas
sensor

0-60,000 ppb/±10%

<333 ppb

PM2.5b

Laser-based light scattering particle sensor 0-1000 µg/m3/±15 µg/m3 or 15%

<15 µg/m3

VOC: volatile organic compound.

b

PM2.5: fine particulate matter.

EMA is a survey approach that uses repeated assessment of
participants to capture behaviors and experiences in a real-time
context. This methodological approach maintains the ecological
validity of reported behaviors and decreases the impact of recall
bias because surveys are sent periodically to participants through
electronic devices [35]. EMA is particularly useful when trying
to understand the context of symptoms or behaviors. Available
literature that combines the EMA methodology with asthma
research focuses primarily on asthma-related outcomes such as
symptoms, control, quality of life, history, and medication
adherence and their relationship with stress (ie, perceived stress,
mood, hassles, and social support) [36-38]. The ability to time
stamp behaviors, events, and experiences and determine whether
they present a positive or negative health impact is valuable
when seeking to understand the complexity of multiple risk
https://www.researchprotocols.org/2022/8/e39887
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factors and multiple environmental and behavioral interactions.
EMA data will be collected electronically using the PiLR EMA
software platform, which can be installed on a personal
smartphone (iOS or Android) [28]. Data captured will be
transmitted to the PiLR EMA platform and stored in a secure
database in the cloud. Participants will receive prescheduled
notifications asking them to complete small surveys. In addition,
we collaborated with PiLR staff to configure the EMA platform
to send EMA notifications based on certain logics and triggers
(ie, VOC and PM2.5 readings exceeding the optimal ranges
outlined in Table 1). Researchers can access the PiLR dashboard
to monitor participants’ use of the EMA app and review their
data.
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The ZEPHYRx Spirometer system allows for laboratory-quality
pulmonary function tests (PFTs) at home, such as forced vital
capacity (FVC), FEV1, FEV1/FVC, and flow-volume loop [39].
The system consists of a Food and Drug Administration
(FDA)–approved handheld Bluetooth spirometer (MIR
Spirobank Smart), and a mobile application that works on a
smartphone or tablet device. The spirometer measures 49 × 109
× 21 mm and weighs 60.7 grams. Participants will share PFT
results through the ZEPHYRx app, and the research team
members will access a Health Insurance Portability and
Accountability Act (HIPAA)–compliant portal to view
participants’ PFT results in real time. An in-app video coaching
feature guides the participant through the PFT maneuver. Each
maneuver conducted by the participant creates a time and
date–stamped American Thoracic Society standard PFT report
accessible through the portal. Deidentified data will be exported
from the dashboard as a .CSV file.

Participants and Recruitment
Participants
This study builds on data collected from the GCAS, a
cross-sectional online survey we conducted in 2020 to examine
how the COVID-19 pandemic affected the prevalence of
disinfectant use among adults with asthma and to assess the
association between the frequency of disinfectant use and asthma
control as measured by the Asthma Control Test (ACT) [14].
Over 1300 individuals responded. Of those, 93.4% (n=934)
indicated they are based in the United States, 78.5% (n=783)
are female, about 23% (n=225) indicated a minority
race/ethnicity, and 741 agreed to be contacted for follow-up
research. About 57% (n=422) used disinfectant/cleaning
products ≥5 times per week.

Inclusion/Exclusion Criteria
Eligibility criteria include GCAS participants who (1) indicated
willingness to be contacted for future research and provided an
email address or phone number and (2) reported high use of
disinfectant/cleaning products since COVID-19 (≥5 per week)
and current ACT ≤19 or ≥2 asthma exacerbations in the past 12
months. The commonly used and validated ACT includes 5
items addressing asthma symptoms, use of rescue medications,
and effect of asthma on daily functioning. Responses are
summed for total ACT score with scores ≤19 indicating asthma
that is not well controlled [40,41]. Non-US residents and
non-English speakers are excluded. We will strive to have at
least 20% of the sample represent ethnic/racial minority
populations.

Recruitment
A total of 50 individuals with at least 20%-40% of the sample
representing individuals who self-identify as being of a minority
race/ethnicity (Hispanic, Black or African American, American
Indian or Alaska Native, Asian, Native Hawaiian or other Pacific
Islander, Arab, multiracial, or other race) who meet
the eligibility criteria will be randomly selected and invited to
participate in this study via email or phone. Invites will be sent
to selected individuals on a staggered timeline based on
response rate and positive participation interest. Participants
will be randomized within their participant category (ie, White
https://www.researchprotocols.org/2022/8/e39887
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or minority race/ethnicity). Participants within each category
will be randomly assigned an order number using a random
number generator in Excel (Microsoft). Participants will be
recruited in the order of their random assignment until we have
recruited a total of 50.
Using the randomized order assignment, invitations will be sent
to 2 to 5 individuals from each group at a time, with the intent
of enrolling initially up to 5 participants at any 1 time. If fewer
than 5 consent to participate in any wave of invitations,
invitations will be sent to the next potential participants in the
randomized order assignment. We will scale up to 10 to 15
enrolled participants once we have passed the initial start-up
period. The staggered recruitment process will be repeated until
50 individuals including at least 20%-40% minorities have
completed study participation. Recruitment will focus on equal
numbers from each participant category (ie, 25 each). However,
given the smaller initial pool, if we are unable to recruit 25
minority participants, additional participants will be recruited
from the White participant pool until a total of 50 participants
are enrolled.
Interested individuals will be directed to a Research Electronic
Data Capture (REDCap) survey link to confirm willingness to
participate, verify eligibility, and provide current contact
information. REDCap will be formatted to automatically send
2 additional email invitations 1 week apart if no response is
received. If no response is received after the second email
invitation and a phone number is provided, a phone call contact
will be attempted. If no phone number is provided, a third
follow-up email will be sent. A total of 3 contact attempts over
a 3-week period with 1 week between each contact will be made
to each invited individual. We will randomly select replacements
if no response is received after 3 contact attempts, lack of
interest is indicated, or inclusion/exclusion criteria are not met.

Development and Testing of EMA
Four types of EMA surveys will be sent to participants: a daily
morning survey (ie, Daily Survey) inquiring whether participants
had asthma symptoms and requesting participants use their
ZEPHYRx spirometer; 2 daily random surveys (ie, Random
Surveys) to assess disinfectant use and asthma symptoms and
remind those with asthma symptoms to use their spirometer;
and 2 triggered surveys based on elevated VOCs and/or PM2.5
levels as captured by Awair Omni. The first triggered survey
(ie, Air Quality Event Survey) will be sent to participants as
soon as elevated levels of VOCs or PM2.5 levels are detected to
assess behaviors or environmental changes that may have caused
elevation, ask participants to report any asthma symptoms they
are experiencing, and remind them to use their spirometer. The
second triggered survey (ie, Air Quality Follow-up Survey) will
follow 1 hour after the trigger event (ie, elevated VOC or PM2.5)
and will assess interventions by participants to improve the
indoor air quality or reduce their exposure (eg, open a window,
leave the room) and any ongoing asthma symptoms. All these
surveys were built on the PiLR dashboard by study team
members after receiving orientation by PiLR staff. After creating
the surveys, research team members were added as
“participants” to allow for rigorous testing of the surveys,
prompts, skip logics, and so on. Sending EMA surveys triggered
JMIR Res Protoc 2022 | vol. 11 | iss. 8 | e39887 | p. 5
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by Awair Omni readings required significant programming
conducted by PiLR staff. Primary considerations for scheduling
the triggered surveys were timing of the survey prompt relative
to the event (ie, prompt sent as close to the event as possible)
while reducing burden on participant for the number of prompts
received (ie, VOC/PM2.5 levels may “bounce” above and below
the threshold several times within a small interval of time).
Real-time data resulted in frequent prompts to respond to the
same event, whereas 5-minute averages could result in delay of
a few minutes between actual event and the deployment of the
survey prompt. Several team members received Awair Omni
devices and used them to assess the functionality and potential
burden on participants and test the link between Awair Omni
readings and EMA triggered surveys to ensure that the proper
link is established and real-time data on VOCs and PM2.5 are
captured that will trigger EMA surveys.

with step-by-step pictures so a participant could easily follow
and pinpoint any missteps. The currently available user guides
from the specific companies (ZEPHYRx, Awair Omni, and
PiLR EMA) were used as templates, with additional specificity
added as needed. For each device, research team members
downloaded the app, set up the device, took screenshots of the
processes, and wrote step-by-step instructions of the set-up.
Issues faced while developing the guides included variations
between phone types (eg, iPhone, Android) and software updates
that occurred during testing requiring adjustments in the guides.
An asthma-focused community advisory board hosted and led
by the Chicago Asthma Consortium was utilized to review the
guides and provide feedback. This feedback was incorporated
into each guide. Suggestions included having study team contact
information readily available in case of any issues and using
highlighted boxes to relay important information.

Development of Participant Guides for Research Tools

Baseline Measures

How-to guides were developed to describe the set-up and use
of each research tool. The goal was to create a seamless guide

Measures that will be administered at baseline via REDCap are
outlined in Textbox 1.

Textbox 1. Measures to be administered at baseline via Research Electronic Data Capture (REDCap).
1.

Adult Asthma History includes 5 items adapted from the Behavioral Risk Factor Surveillance System Survey [42] and 3 items from the Airborne
Exposures PROMIS (Patient-Reported Outcomes Measurement Information System) Pool V1.0 Dyspnea Airborne Exposure. Four items address
participants’ recent contact with health care professionals for asthma. A fifth item addresses changes in routine work/activities due to asthma.
An additional 3 items address airborne allergens, pollutants, and living in an area with extreme temperature changes using yes/no response options.

2.

Adult Asthma Adherence Questionnaire includes 5 items on following a prescribed asthma medication plan and barriers to following that plan
[43].

3.

Health Behaviors includes items addressing exercise, use of alcohol, vaping products, marijuana, and cigarettes.

4.

Home Environmental Exposure data include time typically spent at home, exposure to residential secondhand smoke, use of hand sanitizer,
disinfectants, room where most time is spent in the home, potential asthma triggers in that room (carpeting, vacuuming, flooring), potential
asthma triggers in the room participants sleep in, and cleaning products used in the shower/tub, kitchen, and on furniture. Additional data will
include frequency of cleaning these areas, exposure to fragrances in the home, use of dryer sheets, presence of plants in the home, use of allergy
control covers for pillows and mattress, pets in the home, heating, ventilation, use of a humidifier, having an attached garage, and use of pesticides
in the home [44,45].

5.

Demographics include where participants live, education level, occupation, ZIP code, health insurance, rent/own home, type of home, number
of people in the home, number of bedrooms, 8 items addressing feelings of worry/tiredness/anxiety, self-rated physical health, comorbidities,
height/weight, COVID-19 exposure/infection status, COVID-19 vaccine status, face mask, impact of COVID-19 on finances/employment, and
an open-ended question to address any additional concerns.

6.

In terms of emotional support the PROMIS_SF_V2 Short Form 4A measures perceived feelings of support, being cared for, and valued (4 items)
[46]. Higher scores indicate higher perceived emotional support.

7.

Perceived Stress Scale includes 4 items measuring the degree to which situations in one’s life are appraised as stressful. Higher scores indicate
an increased level of perceived stress [47].

Subsequent Measures

research team to identify patterns as well as any adjustments
that are needed.

Seven-Day Check-in

Participant Feasibility Assessment

Open-ended questions will be asked to identify any
troubleshooting areas, determine if adjustments need to be made,
and assess ease of use of the app/devices. Participants will be
asked how things went with each of the study tools (Awair Omni
indoor air quality monitor, ZEPHYRx spirometer, and EMA).
Additional things to be asked include feedback on the set-up
materials provided prior to data collection, interactions with
research staff, queries if a participant is nonresponsive to EMA
prompts, and an open-ended general item about how the study
is going. Interactions will be recorded and reviewed by the

At the end of the 14-day data collection period, participants will
be asked to respond to a short REDCap survey assessing
usability of the Awair Omni indoor air quality monitor (10
items), PiLR EMA Health app (10 items), and the ZEPHYRx
home spirometer (10 items), with response ranging from 1
(strongly agree) to 5 (strongly disagree). After each section,
there will be an open-ended item for participants to comment
on what they liked or did not like about each study tool (Awair
Omni air quality monitor, EMA, ZEPHYRx home
spirometer). A random sample of 20 participants will be
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interviewed to further explore these factors using 4 open-ended
questions: (1) “How did the study work for you?” (2) “Tell us
what you liked/didn’t like about the indoor air quality monitor.”
(3) “How did you feel about the integration of the various tools
(Awair Omni, ZEPHYRx, and EMA) in the study?” (4) “Is there
anything else you’d like to tell us?”

Data Analysis Plan
Each day of observation will be divided into 4 periods between
6 AM and 10 AM that will be 4 hours each. Data from
event-contingent prompts as well as fixed (ie, daily morning
and 2 random) prompts will be analyzed. Multiple
event–contingent prompts may occur within the same 4-hour
window, in which case data will be averaged across all
event-contingent prompts during that period. The daily morning
survey is scheduled so that it will always occur within the first
4-hour window of the day, and the random prompts are
scheduled so only 1 will occur within any of the 4-hour
windows.
To address the first aim of this study, we will assess compliance
in 4 areas: survey response, spirometry use, interventions to
reduce exposure, and air quality monitoring. Survey response
compliances will be measured using EMA prompts and defined
by the total number of completed prompts of each type out of
the number of EMA prompts of each type received. Behavioral
compliance to use of the spirometer will be assessed as the
number of times the participant used the spirometer out of the
number of times the participant was prompted to use it.
Compliance to completing interventions to reduce exposure
following an air quality event will be assessed using completed
follow-up surveys as the number of times the participant
reported taking action to reduce exposure out of the number of
event-contingent surveys where the participant indicated they
were in the home at the time of the event. Air quality monitoring
compliance will be assessed as the duration the indoor air quality
monitor is used by each participant out of the total study time.
Compliance in all 4 areas will be assessed for the entire study
period as well as within the 4-hour daily windows.
The quantitative participant assessment of acceptability,
appropriateness, and feasibility will be analyzed descriptively.
Differences in use and acceptance by participant demographics
will be examined to identify factors (eg, age, asthma symptoms,
overall health, education) that may make participants more or
less likely to use the monitors or respond to prompts. Qualitative
interview data will be transcribed and uploaded to Dedoose
qualitative analysis software (SocioCultural Research
Consultants) for content analysis.
To address the second aim of this study, we will analyze baseline
data on the current use and frequency of disinfectants/cleaners
and exposure to environmental triggers (eg, secondhand smoke).
Real-time self-reported data on disinfectant use throughout the
study period obtained through the EMA studies will be analyzed
for total use during the study period as well as trends within
and across the daily time intervals (eg, levels reporting in
morning versus evening survey windows). We will determine
the prevalence of disinfectant use and frequency (percent of
EMA prompts at which disinfectant use is reported). We will
also obtain data from the Awair Omni dashboard to determine
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the number of times VOC and PM2.5 levels exceed optimal
levels, average daily levels, average levels per time, and
fluctuations in VOC and PM2.5. We will identify possible
environmental triggers that contribute to high levels of VOCs
and PM2.5 and event-contingent prompts.
To address the third aim of this study, we will determine the
baseline level of asthma control as reported by the ACT. We
will use EMA to determine the level of asthma control over the
study period as indicated by (A) asthma symptoms reported at
each prompt and over the 14 days, (B) number of time periods
in which participants report asthma symptoms, and (C) lung
function as measured by FEV1% predicted within 30 minutes
of each event-contingent prompt. Asthma control will also be
evaluated using EMA by exploring differences in variability in
lung function.
We will use the data collected using the EMA approach to
evaluate the fourth aim of this study. EMA data are multilevel,
with time windows (level 1) nested in individual participant
information (level 2). The exposure variables will include (1)
baseline person-level variables such as self-reported use and
frequency of disinfectant/cleaner use and PM2.5 exposure, (2)
time-level exposure frequency variables defined by the number
of times VOC and PM2.5 levels reach or exceed the threshold
for the optimal readings per week, (3) time-level exposure level
variables defined by the average scores of VOC and PM2.5 levels
in the time windows considered in the analysis, and (4)
time-level exposure duration variables defined by the total time
within the time windows that the VOC and PM2.5 levels were
elevated. The outcome variables that we will consider include
occurrence of any asthma symptoms, inhaler use, and FEV1%
predicted within 30 minutes from the event-contingent prompt.
We will use multilevel binary logistic regression to examine
the associations between the exposure variables and binary
outcome variables. We will also use multilevel linear regression
to examine associations between the exposure variables and
predicted FEV1%. We will control for both level 1 variables
(time of day, day of week) and level 2 variables (baseline asthma
symptoms, demographic characteristics). Using available time
stamps from the indoor air quality monitor, EMA, and the
spirometer, we will also explore average lag time between an
event-contingent prompt and self-reported asthma symptoms
using multilevel survival analyses.

Results
This project received funding in March 2021. The first year of
this project has been spent focusing on determining the
feasibility and usability of using an EMA to assess self-report
of residential environmental exposures, home monitoring or
environmental exposures, and lung function. This has involved
creating participant research materials and developing and
coordinating 4 diverse software platforms: REDCAp surveys,
ZEPHYRx spirometer, Awair Omni home air quality monitor,
and PiLR EMA. We pilot tested our procedures and began
recruitment in March 2022. We anticipate study completion in
2023.
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Discussion
Summary
This study contributes to our knowledge of the real-time impact
of VOCs and PM2.5 in the home environment on asthma in
several ways. First, it addresses how increased cleaning and
disinfecting practices could impact asthma control in people
with asthma. This consideration is particularly relevant
considering the COVID-19 pandemic, during which people
have dramatically increased their use of disinfectants. This study
also addresses the methodological shortcomings of previous
studies of the home environment of adults with asthma, as we
uniquely use real-time collection of symptoms data with EMA
to examine the effects of environmental triggers on adult asthma
symptoms, real-time objective residential exposure data (VOCs,
PM2.5), and we collect an objective measure of asthma control
with the measurement of lung function.

Strengths
This study has several strengths. First, it builds on an ongoing
study and will be conducted with individuals who have agreed
to be recruited for future studies and thus facilitate enrollment.
Second, participants will be drawn from a wide geographic area
in the United States, which increases broad representation of
participants. We will gather real-time environmental exposure
data and indicators of asthma control in unregulated indoor
home spaces without actual in-person contact. Findings from
this study have the potential to impact recommendations for
indoor use of disinfectants/cleaners for those with asthma and
guide further research.

Anticipated Challenges and Limitations
There are a number of challenges we anticipate as we launch
this feasibility study. First is the presence of the digital divide
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and the extent to which we may encounter it. The concept of
the digital divide acknowledges that communities across nations
have differing levels of access to technology, including
smartphones, internet, and broadband infrastructure, which may
be related to geography (rural versus urban), generational
differences, comfort level with technology, and finances. As
part of the feasibility design, we will document the impact of
this differing access to better address challenges of the digital
divide and promote inclusion of varied communities in future
studies involving the indoor home environment and technology
platforms.
Along with documenting the extent of the digital divide
encountered in this study, our team is interested in addressing
any ethical concerns that arise with using multiple technology
platforms in the indoor home environment. Real-time data
collected by Wi-Fi and Bluetooth–enabled devices may bring
about unique ethical concerns that must be addressed to ensure
privacy and confidentiality. Our team will address any ethical
concerns in real time with the guidance of our institutional
review board, and we will strive to share best practice when
bringing such technology into homes with our research
participants as partners in this process. The feasibility design
of this study will allow us to purposefully address any challenges
that may arise in a larger, powered study.

Conclusions
Findings from this study will provide preliminary data for a
powered study to develop innovative intervention strategies for
people with asthma and address the impact of changes in
environmental exposures related to COVID-19, thereby
enhancing our preparedness for future infectious disease
outbreaks. This has implications for risk reduction in people
with asthma to help improve asthma self-management using
personal monitors and sensors for individually tailored exposure
profiles.
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